Twist Bioscience Corp

Healthcare · EUR · F

0ME

Price

€49.344

+7.98%

Cap

€3.54B

Earnings

—

30d Trend

-6.1%

0ME

Loading chart data...

0 days · % change from startPowered by Brain47

BRAIN47 SIGNAL

STRONG

Risk Level80

Quality50

Momentum88

Technical58

Fundamentals50

Raw weighted: 63×Macro 0.99 (−1%)=62

RISK

80/100

90d Volatility

71.1%High

ATR %

6.3%High daily moves

Max Drawdown (1Y)

-38.2%Volatile

QUALITY

50/100

MOMENTUM

88/100

12-1M Momentum

+118.0%Strong uptrend

6-1M Momentum

+92.0%Positive

1M Return

+8.5%Strong recent gains

TECHNICAL

58/100

RSI (14)

64.1Neutral

Price vs SMA200

+62.6%Bullish trend

MACD

+0.90Bullish momentum

Bollinger Band

94%Near upper band

SMA Cross

Death CrossDeath Cross

Trend Quality (KER)

0.122Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 60%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months65

3-12 months ★85

1-5+ years50

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate Twist Bioscience Corp at 62/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 88/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (88) and Technical (58) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 62/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.